Skip to main content
Elsevier Sponsored Documents logoLink to Elsevier Sponsored Documents
. 2022 Jan 15;138:144–154. doi: 10.1016/j.actbio.2021.11.011

Hydroxyapatite-decorated Fmoc-hydrogel as a bone-mimicking substrate for osteoclast differentiation and culture

Mattia Vitale a, Cosimo Ligorio a, Bethan McAvan a, Nigel W Hodson b, Chris Allan c, Stephen M Richardson a,, Judith A Hoyland a,, Jordi Bella a,
PMCID: PMC8756142  PMID: 34781025

Abstract

Hydrogels are water-swollen networks with great potential for tissue engineering applications. However, their use in bone regeneration is often hampered due to a lack of materials’ mineralization and poor mechanical properties. Moreover, most studies are focused on osteoblasts (OBs) for bone formation, while osteoclasts (OCs), cells involved in bone resorption, are often overlooked. Yet, the role of OCs is pivotal for bone homeostasis and aberrant OC activity has been reported in several pathological diseases, such as osteoporosis and bone cancer. For these reasons, the aim of this work is to develop customised, reinforced hydrogels to be used as material platform to study cell function, cell-material interactions and ultimately to provide a substrate for OC differentiation and culture. Here, Fmoc-based RGD-functionalised peptide hydrogels have been modified with hydroxyapatite nanopowder (Hap) as nanofiller, to create nanocomposite hydrogels. Atomic force microscopy showed that Hap nanoparticles decorate the peptide nanofibres with a repeating pattern, resulting in stiffer hydrogels with improved mechanical properties compared to Hap- and RGD-free controls. Furthermore, these nanocomposites supported adhesion of Raw 264.7 macrophages and their differentiation in 2D to mature OCs, as defined by the adoption of a typical OC morphology (presence of an actin ring, multinucleation, and ruffled plasma membrane). Finally, after 7 days of culture OCs showed an increased expression of TRAP, a typical OC differentiation marker. Collectively, the results suggest that the Hap/Fmoc-RGD hydrogel has a potential for bone tissue engineering, as a 2D model to study impairment or upregulation of OC differentiation.

Statement of significance

Altered osteoclasts (OC) function is one of the major cause of bone fracture in the most commonly skeletal disorders (e.g. osteoporosis). Peptide hydrogels can be used as a platform to mimic the bone microenvironment and provide a tool to assess OC differentiation and function. Moreover, hydrogels can incorporate different nanofillers to yield hybrid biomaterials with enhanced mechanical properties and improved cytocompatibility. Herein, Fmoc-based RGD-functionalised peptide hydrogels were decorated with hydroxyapatite (Hap) nanoparticles to generate a hydrogel with improved rheological properties. Furthermore, they are able to support osteoclastogenesis of Raw264.7 cells in vitro as confirmed by morphology changes and expression of OC-markers. Therefore, this Hap-decorated hydrogel can be used as a template to successfully differentiate OC and potentially study OC dysfunction.

Keywords: Osteoclast culture, Bone tissue engineering, Peptide hydrogel, Hydroxyapatite, Macrophage

Graphical abstract

Image, graphical abstract

1. Introduction

Bone is a highly dynamic and hierarchically organised organ, consisting of a complex network of cells embedded in a 3D structure of organic-inorganic nanocomposite, which confers remarkable mechanical performance, including high strength and fracture toughness [1,2]. Bone is constantly self-renewing through a finely regulated balance of two processes: osteoclastogenesis, through bone-resorbing osteoclasts (OCs), and osteoblastogenesis through bone-forming osteoblasts (OBs) [3], [4], [5]. Disruption of the equilibrium between these processes can cause bone defects or may lead to increased risk of bone fractures [6]. OCs are hematopoietically-derived multinucleated cells that play an essential role in maintaining bone turnover and they are key players in bone diseases, such as osteoporosis and different forms of cancer [5,7,8]. Bone tissue engineering can provide useful tools to mimic the natural bone microenvironment and study the mechanisms involved in bone diseases. Synthetic or natural biomaterial scaffolds have been used to promote the migration, proliferation, and differentiation of pluripotent cells into bone cells [9,10]. Hydrogels are water-swollen polymer-based networks, synthesized from hydrophilic monomers, which are able to form self-supporting systems that do not dissolve in water [11]. Hydrogel-based scaffolds are currently used for bone studies because they can provide a realistic hydrophilic 3D environment that supports cell attachment, spreading and new bone ingrowth [12], [13], [14]. However, a successful scaffold for bone regeneration should take into account the complexity of the bone turnover and provide biomaterials that can regulate OC activity accordingly [15]. Yet, very little is known about the interaction of OCs and biomaterials.

Self-assembling peptide-based hydrogels have shown physicochemical features mimicking native extracellular matrix (ECM), due to their high percentage of water (> 90% of the dry weight), tuneable mechanical properties and nanofibrous architecture [16], [17], [18], [19]. They also offer multiple avenues for the design of bioactive materials by incorporating natural motifs for the dynamic control of the materials final structures and their interactions with cells [20]. It has been demonstrated that aromatic short peptides are able to form stable peptide nanotubes through a combination of hydrogen-bonding and π-stacking interactions [21]. In particular, the chemical coupling of aromatic protecting groups such as 9-fluorenylmethoxycarbonyl (Fmoc) to the N-terminus of some peptides helps them to spontaneously assemble into self-supporting hydrogels [22]. Amongst Fmoc-functionalised peptides, Fmoc-diphenylalanine (Fmoc-FF) has been demonstrated as an effective low molecular weight gelator, forming a rigid cylindrical-shape dipeptide hydrogel without the need for additional crosslinking agents [23]. Additionally, the chemical properties of these hydrogels can be chemically and biologically engineered by changing the amino acid sequence in order to enhance cell adhesion and cell proliferation [24,25]. Furthermore, by tailoring the peptide concentration, the hydrogels’ stiffness can be tuned allowing a precise control of the scaffold's final properties and the behaviour of cells cultured on them [26,27]. However, formulations leading to stiffer hydrogels may also limit the materials performance and/or the cell response. Hence, in the last decade, innovative approaches to reinforce hydrogels with different components used as “nanofillers” have been developed [12,[28], [29], [30]]. More recently, hydroxyapatite (Hap) nanoparticles have been used in tissue engineering studies as reinforcement to improve the scaffold's mechanical properties as well as cytocompatibility and bioactivity [31], [32], [33], [34]. Hap is the principal component of the mineral phase of bone, and it is also used as an extra scaffold component for bone regeneration [35]. Therefore, it is commonly used to mimic the natural bone due to its similarities in chemical composition, structure, and density [36]. Moreover, it has been shown that the nanotopography and chemical composition of the hydrogels are able to influence directly OC activity promoting OC differentiation, increasing cell number, and enhancing Tartrate-Resistant Acid Phosphatase (TRAP) activity [37,38].

For this reason, we have employed Hap nanopowder to create a bone-mimicking substrate to be used as a scaffold for successful culture and differentiation of OC precursors into OCs. We report here the incorporation of Hap within Fmoc-FF, Fmoc-serine (Fmoc-S) and Fmoc-arginyl-glycyl-aspartate (Fmoc-RGD) hydrogels to formulate Hap-containing, peptide-based hydrogel nanocomposites. We provide data on the characterization of these Hap-decorated hydrogels’ ultrastructure, mechanical properties under oscillatory rheometry, and cytocompatibility. Our results demonstrate that our formulated RGD-functionalised hydrogels can successfully incorporate Hap nanopowder to create a stiffer hydrogel microenvironment for OC cell culture. These hydrogel systems were shown to be biocompatible and are able to support cell adhesion and osteoclastogenesis through in vitro differentiation of Raw 264.7 pre-OC cells, as demonstrated by a typical OC morphology (presence of an actin ring, multinucleation, and ruffled plasma membrane) and increased TRAP expression. Thus, we envisage that this system could be used as a new biomaterial platform to culture and successfully differentiate OCs for tissue engineering applications, and ultimately provide a specialised scaffold to investigate the regulation of OC differentiation.

2. Materials and methods

2.1. Materials

Fmoc-FF/S (Fmoc-diphenylalanine/serine, 1:1 ratio) and Fmoc-FF/S/RGD (1:0.5:0.5 ratio) peptide powders were provided by Biogelx Ltd, UK. Peptide purity was assessed by Biogelx via High Performance Liquid Chromatography (HPLC). Fmoc-FF/S (commercial name Biogelx-S; Batch No. FFS052RM) and Fmoc-FF/S/RGD (commercial name Biogelx-RGD; Batch No. FFSRGD027RM) were 97% and 99% pure, respectively. Hydroxyapatite nanopowder (Ca10(PO4)6(OH)2, particle size < 200 nm), was obtained commercially (Sigma-Aldrich, 677418) and used as received.

2.2. Hydrogel and hap-decorated hydrogels preparation

Peptide hydrogels were prepared according to the manufacturer's protocol. In order to obtain a final hydrogel concentration of 15 mM, 0.0132 g of Fmoc-FF/S and 0.0148 g of Fmoc-FF/S/RGD peptide powder were dissolved in 1 mL of sterile deionized H2O to form a viscous peptide solution referred to as “pre-gel”. For the preparation of hydroxyapatite-containing hydrogels, 1 mg of Hap nanopowder was dispersed in 1 mL sterile deionized H2O using an ultrasonic water bath sonicator for 2 min at room temperature. This solution was then used to further dissolve the peptide powders using the above-mentioned ratios. When used for cell culture applications, “pre-gel” solutions were sterilized under UV light for 20 min prior hydrogel crosslinking induced by addition of high glucose Dulbecco's Modified Eagle's Medium (with 4.5 g/L glucose, L-Ala-L-Gln, sodium pyruvate and sodium bicarbonate) (DMEM, Sigma-Aldrich, FG0445, UK).

2.3. Atomic force microscopy (AFM)

Hydrogels with and without Hap were diluted from 15 mM to 5 mM using double deionised water (ddH2O). Samples for AFM analysis were prepared by depositing 100 µL aliquots of diluted hydrogel solutions onto freshly cleaved mica (Agar Scientific, UK) for 60 s at room temperature and allowing them to adhere. Excess liquid was then removed by capillary action using Whatman No. 1 filter paper. Hydrogel-coated mica samples were finally washed five times using 200 µL of ddH2O and left to air-dry overnight before imaging. Imaging was performed using a Bruker Multimode 8 AFM with a NanoScope V controller and a "J" scanner, operating under the NanoScope Controller software (v 8.15) (Bruker, USA). Scanning was performed in air at room temperature in ScanAsystTM (Peak Force Tapping) mode, using ScanAsyst-AirTM probes (Bruker AXS S.A.S, France) with nominal resonant frequency (f0) and spring constant (k) of 70 kHz and 0.4 Nm−1 respectively. AFM images (2 µm2) were acquired with a 512 × 512 pixels resolution at a scan frequency of 1 Hz. Height data was first-order flattened, and average fibre/nanopowder widths were determined and analysed using the NanoScope Analysis software (v 1.40) (Bruker, USA). For this experiment, N=200 fibres were counted as a measure of homogeneity of the hydrogels structure.

2.4. Oscillatory rheometry

The viscoelasticity of the hydrogels, with and without Hap, was measured on a Malvern Kinexus Pro rheometer using a 20 mm/diameter parallel-plate geometry with a 0.5 mm gap size. Samples were prepared by pipetting 300 µL of pre-gel solution into a 24-well plate containing 1 mL/well of DMEM cell culture medium to form a spheroid-shaped hydrogel. After incubation for 2 h, fully formed hydrogels were transferred onto the rheometer plate. The elastic and viscous moduli of the hydrogels were recorded as a function of frequency between 0.1 and 100 Hz (shear strain of 0.1 %), at 25 °C.

2.5. Raw 264.7 hydrogel cell culture

Murine macrophage Raw 264.7 cells (TIB-71™) were purchased from ATCC and maintained in monolayer culture using DMEM containing 10% (v/v) foetal bovine serum (FBS) and 5% (v/v) Penicillin-Streptomycin-Amphotericin antibiotic mixture (PSA, 100 units/mL penicillin, 100 µg/mL streptomycin, 0.25 µg/mL amphotericin) (Sigma-Aldrich, UK). Upon reaching 70-80% confluency, cells were gently detached from the tissue culture flask by scraping and the cell suspension was pelleted by centrifugation (400 × g for 5 min). After counting cells with an automated cell counter (Countess™ 3, Invitrogen™), fresh culture medium was added to obtain the desired cell density. Hydrogels with and without Hap for cell culture were prepared 24 h in advance following the procedure described above for the pre-gel solution, followed by pipetting 200 µL of such pre-gel solution into the inner well of a 35 mm glass bottom dish for confocal microscopy (VWR, UK, 734-2905). 2 mL of DMEM were added to the pre-gel solution to induce gelation. The following day, DMEM used to crosslink the hydrogels was removed and 2 mL of cell suspension were added to the surface of the hydrogels to a final cell density of 4 × 105 cell/mL. Medium was changed every 24 h for the first two days, and then every other day for up to 7 days.

2.6. F-actin staining: cell morphology

Morphology and cytoskeleton arrangement of Raw 264.7 cells cultured on Fmoc-FF/S and Fmoc-FF/S/RGD hydrogels, with and without Hap, were investigated using Alexa Fluor 488 Phalloidin (Invitrogen, UK, A12379). After 7 days in culture, medium was removed from the hydrogels and cells were fixed in 4% (w/v) paraformaldehyde (Sigma-Aldrich, UK) for 30 min and permeabilized in 0.5% (v/v) Triton X-100 solution (Sigma-Aldrich, UK) in phosphate buffered saline (PBS) (Gibco, UK) for 5 min. The samples were then incubated with 1:200 Alexa Fluor 488 Phalloidin for 30 min. After 3 × washes in PBS, nuclei were counterstained with 1:8000 Hoechst in PBS (Thermo Scientific, 33342, UK). Stained samples were imaged by using a Leica SP8 upright dipping lens confocal microscope with excitation filters of 495 nm (green, Alexa Flour) and 351 nm (blue, Hoechst). Cell analysis was performed by using ImageJ v. 1.51. In order to produce three 8-bit greyscale images, individual channels were obtained from the composite fluorescence images in red, green and blue (RGB). Greyscale images were thresholded using Huang's approach [39] and touching cells were separated into individual objects by applying a watershed algorithm [40]. Cell diameter and nuclei of at least 100 cells were measured by using the “analyse particle” plugin from ImageJ.

2.7. Scanning electron microscopy (SEM)

Hydrogel morphology and cell-hydrogel interaction were evaluated by Scanning Electron Microscopy (SEM). Briefly, 100 µL of the pre-gel solutions with and without Hap were pipetted into ThinCert well inserts (0.4 µm pore size Greiner Bio-One Ltd, UK). The inserts were then placed into 24-well plates and incubated at 37 °C with a total volume of 1.3 mL DMEM to fully crosslink the hydrogels. The following day Raw 264.7 cells were seeded onto the hydrogels as described above. After 7 days, cells were washed in PBS and fixed in 2.5 % (w/v) glutaraldehyde (Sigma-Aldrich, UK) and 4% (w/v) paraformaldehyde (Sigma-Aldrich, UK) in 0.1 M HEPES buffer (Sigma-Aldrich, UK). After rinsing the samples in PBS, for cell observation all samples were dehydrated in a graded ethanol (EtOH) series (25, 50, 75, 95, and 100 % v/v EtOH/water). Samples were maintained at 100 % EtOH and dried in a K850 Critical Point Drier (CPD, Quorum Technologies, UK). After the CPD step, samples were transferred into metallic pins and coated with gold palladium alloy using an SC7620 Mini Sputter Coater (Quorum). Samples were then imaged on a Quanta 250 FEG SEM (Thermo Fisher Scientific) at 20 kV.

2.8. Viability assessment

A Quant-iT™ PicoGreen™ dsDNA Assay Kit (Invitrogen P11496) was used to assess the viability of Raw 264.7 cells cultured on the Hap-decorated Fmoc-FF/S/RGD hydrogels. Cells were cultured into ThinCert well inserts as described above (Section 2.7). At each time point (24 h, 48 h, 5 days and 7 days), medium was removed from the inserts and the cell-cultured hydrogels were transferred into 1.5 mL Eppendorf tubes by gently peeling off the membrane of the ThinCert inserts. Then, 200 µL of 10 mg/mL Pronase in ddH2O (a commercial mixture of proteases from Streptomyces griseus, Roche, UK) were added to each Eppendorf tube and the mixtures vortexed for 20 s following an incubation of 5 min in a water bath at 37°C. An equal volume of 2 × TE buffer (20 µM Tris-HCl, 2 mM EDTA, 0.4% Triton X-100, pH 7.5; Sigma-Aldrich, UK) was added to each sample in order to extract the dsDNA. 100 µL of the dsDNA were then pipetted into a 96-well plate where an equal volume of PicoGreen Reagent (200-fold dilution in 1 × TE buffer) was added. After 5 min of incubation at room temperature the fluorescence intensity was measured by using a BioTekTM FLx800TM microplate fluorescence reader (excitation wavelengths: 480-512 nm; emission wavelength: 520 nm). The fluorescence intensity measured was normalised using day 1 of culture as a baseline control. All measurements were performed at least 3 times for each time point to ensure reproducibility.

2.9. Live/Dead staining

A Live/Dead assay kit (Invitrogen L3224) was used to assess the viability of Raw 264.7 cells cultured on the Hap-decorated Fmoc-FF/S/RGD hydrogels. Following the manufacturer's protocol, 600 µL of the assay solution containing 4 µM ethidium homodimer-1 (EthD-1) and 2 µM calcein AM were pipetted onto the cell-hydrogel constructs. After 30 min of incubation cells were washed 3 times in PBS and imaged using a Nikon Eclipse 50i fluorescence microscope (emission wavelengths: green channel for live cells 515 nm; red channel for dead cells 635 nm; excitation wavelength: 495 nm). Cell images were collected at 24 h, 48 h, 5 days and 7 days post culture. Three images per time point were acquired.

2.10. TRAP immunofluorescence staining

Differentiation of Raw 264.7 cells into mature osteoclasts was determined by using a TRAP monoclonal antibody. After 7 days in culture on hydrogels, cells were stained following the procedure described in section 2.6 using 1:200 anti-TRAP mAb conjugated Alexa Fluor 594 (Santa Cruz Biotechnology, UK, sc-376875) in PBS for 90 min. After the incubation time, cells were washed three times for 5 min with PBS and imaged immediately using a Nikon Eclipse 50i fluorescence microscope (excitation wavelength 495 nm). Fluorescence intensity ratio was measured from 100 cells and normalised to the background by using ImageJ v. 1.51.

2.11. TRAP gene expression

Raw 264.7 cells were cultured in Hap-decorated Fmoc-FF/S/RGD hydrogels using ThinCert well inserts, as described above (Section 2.7). After 3 and 7 days post culture the hydrogels were removed from the inserts and transferred to 1.5 mL Eppendorf tubes. Then, 1 mL of TRIzol™ Reagent (Invitrogen, 15596026) was added to each hydrogel and RNA was extracted following the manufacturer's protocol. Quality and quantity were determined using a Nanodrop ND-1000 Spectrophotometer (Nanodrop Technologies). Following the RNA extraction, RNA samples were reverse-transcribed into cDNA using a High Capacity Reverse Transcription Kit (Applied Biosystems, UK). Obtained cDNA was further diluted to 5 ng/µL according to the Nanodrop reading and qPCR was performed in triplicate using a StepOne™ Real-Time PCR System (Applied Biosystems, UK) using TaqMan probes with the universal PCR Master Mix (Life Technologies, 4304437) in a total volume of 10 µL. The TaqMan probe for Trap was used (Mm00475698_m1) and data was analysed using the 2−∆Ct method and normalised to the endogenous house-keeping gene GAPDH (Mm99999915_g1).

2.12. Statistical analysis

All quantitative values are presented as mean ± standard deviation. All experiments were performed using at least three replicates. Data were plotted using Origin 2019b and compared using an unpaired t test, unless stated otherwise. Two levels of significance were used: 0.005 (**) and 0.001 (***).

3. Results and discussion

3.1. Formulation and characterization of the Hydroxyapatite-decorated self-assembled peptide hydrogels

In order to develop multicomponent hydrogels for use as scaffolds for OC culture and differentiation, Fmoc-FF/S and Fmoc-FF/S/RGD were used. These peptide-based formulations form hydrogels through cooperative assembly of the short peptides Fmoc-FF, Fmoc-S and Fmoc-RGD (Fig. 1A), and have been modified here by the incorporation of Hap nanopowder as “nanofiller” in the hydrogel network. It has been demonstrated that modifying scaffolds with calcium phosphate minerals makes them a suitable option for use in bone regeneration studies by increasing their mechanical properties, cytocompatibility and bioactivity [30]. Here, we developed a protocol through which Hap nanoparticles were successfully incorporated within hydrogel networks, without impairing the gelator assembling mechanism (Fig. 1B). Hap nanoparticles were successfully incorporated in both hydrogel formulations by using a viscous liquid dispersion that formed a hybrid gel-like solution when added to the peptide hydrogels (Section 2.2). Different concentrations of Hap nanoparticles (up to 3 mg/ml) were tested. However, Hap, at a concentration of 1 mg/mL, was chosen for this study as it provided the best mechanical properties among all the formulated nanocomposite (Fig. ESI 1). Undecorated pre-gels were clear and transparent, while hybrid pre-gel solutions appeared cloudy, due to the presence of the Hap dispersion (Fig. 1C). All the hydrogels were formed by addition of DMEM, which acts as a source of Ca2+ ions, crosslinking the carboxylate groups of the peptide's C-termini [26]. Resulting hydrogels were stable with and without (w/wo) the presence of Hap, as shown by the glass vial flip test (Fig. 1C). In particular, Fmoc-FF/S/RGD showed a homogeneous distribution of Hap throughout the hydrogels with minimal leaching over time (Fig. ESI 2).

Fig. 1.

Fig 1

Hap-decorated hydrogels protocol development. (A) Molecular structure of the three building blocks Fmoc-FF, Fmoc-S, Fmoc-RGD. The Fmoc-FF/S is made from Fmoc-FF and Fmoc-S. The Fmoc-FF/S/RGD hydrogel is made from these two peptides plus Fmoc-RGD. (B) Schematic representation of the optimised protocol used to incorporate the Hap nanonpowder within hydrogels. (C) Pre-gel and hydrogel vials photograph w/wo the addition of Hap.

Once formulated, the microstructure of each hydrogel was assessed using AFM (Fig. 2). To investigate the effect of Hap addition, two different samples of each hydrogel formulations were prepared w/wo Hap. All four samples showed the typical hydrogel nanofibre morphology with long bundles and extensive fibre entanglement, suggesting that the addition of Hap did not cause impairment of the peptide self-assembling mechanism nor any fibre precipitation (Fig. 2A–D). Fibre width analysis of the Fmoc-FF/S hydrogels w/wo Hap (Fig. 2A,B) shows unimodal distributions in both cases, with average fibre widths of 26 (±7) nm (with Hap) and 29 (±9) nm (without Hap). In contrast, the Fmoc-FF/S/RGD hydrogel without Hap shows a bimodal distribution, with a first peak centred at 19 nm and a second, more populated distribution with peak centred at 44 nm (Fig. 2C). However, after incorporation of Hap the Fmoc-FF/S/RGD hydrogel shows a higher number of thinner fibres (diameter ∼10 nm) and a broad unimodal distribution with marked positive skewness and a peak at 12-15 nm (Fig. 2D).

Fig. 2.

Fig 2

AFM images of the hydrogels studied here, and distributions of fibre widths as measured on the AFM images (A-D). Hydrogel nanotopography of Fmoc-FF/S (A) and Fmoc-FF/S/RGD (C) without added Hap, and Fmoc-FF/S (B) and Fmoc-FF/S/RGD (D) after incorporation of Hap (Scan size 2 µm2, Scale bar 400 nm).

Based on these results, there is little or no difference in fibre width distribution between the Fmoc-FF/S hydrogels w/wo Hap (Fig. 2A-B). We believe that this is due to the lack of interaction between Hap and the two monomers present in the hydrogel, Fmoc-FF and Fmoc-S (Fig. 1A) [41,42]. For similar reasons it is plausible to postulate that the different width distribution observed in Fmoc-FF/S/RGD AFM images (Fig. 2C) is due to the presence of the Fmoc-RGD peptide within the hydrogel structure. Although it does not impair the self-assembly mechanism of the hydrogels, introduction of a third monomer (Fmoc-RGD) causes a bimodal distribution with two populations of thinner and thicker fibres, probably due to steric interference from the RGD groups that may impede fibre-fibre lateral associations, as shown in a similar peptide-based hydrogel system by Green and co-workers [43]. However, based on the width distribution shown in Fig. 2D we hypothesise that the incorporation of Hap nanoparticles to Fmoc-FF/S/RGD hydrogels may induce the peptide nanofibres to form thinner structures, in order to “accommodate” such Hap nanoparticles within the fibrillar structure. As demonstrated by Zhou et al., Fmoc-FF and Fmoc-RGD peptide sequences are able to self-assemble into cylinder-like structures with the RGD motifs present on the fibre surfaces [25]. For this reason, we believe that, during the hydrogel self-assembling mechanism, the presence of Hap in the system “forces” the formation of thinner fibres, due to steric interaction. In fact, it has been shown that the presence of nanoparticles on fibre surfaces decreases the mobility of monomers causing a slow conformational relaxation of the polymers in fibres [44]. Furthermore, we found that, when Hap was incorporated into the Fmoc-FF/S/RGD hydrogels, the Hap nanoparticles appeared to be arranged on the peptide nanofibres in a regular pattern (Fig. 3A). Indeed, the AFM height measurements showed a periodicity of ∼34 nm between the height peaks of the Hap nanoparticles along the fibre axis (Fig. 3B-C). Hap nanoparticle size distribution ranges between ∼ 5 and 25 nm and a tighter distribution of nanoparticles on the fibres can be observed (Fig. ESI 3A,B). It can therefore be proposed that the repeated pattern shown in Fig. 3A-C is due to the Hap nanoparticles decorating the nanofibres at each point of periodicity. It has been demonstrated that polar and positively charged amino acids (such as Arginine, Arg) can strongly interact with and adsorb Hap nanoparticles [42,45]. Due to the presence of positively charged Arg side chains in the exposed RGD motifs on the peptide nanofibre surface, we hypothesise that Hap nanoparticles are interacting with the peptide nanofibres, resulting in a more homogenous incorporation of Hap nanoparticles in this hydrogel compared to Fmoc-FF/S, which lacks the RGD motif (Fig. 2A-B). In particular, due to the electrostatic attraction between Arg and Hap (positively and negatively charged at formulation), it is likely that the Hap nanoparticles are able to “coat” the RGD-containing nanofibres to successfully form hybrid hydrogels, as schematically proposed in Fig. 3D. In fact, we believe that, similar to what shown by Cerruti and colleagues [46], the RGD motif present here exposes both positively (Arg) and negatively (Asp) amino acid side chains and these may be involved in large-range electrostatic interactions (Fig. 3A) [42,45,47].

Fig. 3.

Fig 3

Topography of Hap-decorated Fmoc-FF/S/RGD hydrogels. (A) 2 µm2 AFM images of Fmoc-FF/S/RGD incorporating Hap in a repeating pattern. (B) Enlarged AFM image of the area outlined in A showing Hap nanoparticles decorating the Fmoc-FF/S/RGD fibres. (C) Corresponding height profile of the linear scan indicated by the white arrow in B. (D) Schematic model of a hydrogel fibre incorporating Hap. Scale bar for A is 400 nm. Scale Bar for B is 200 nm.

3.1.1. Mechanical characterization of the hydrogels

In order to assess the effect of Hap incorporation on the hydrogels’ mechanical properties, we analysed by rheology the viscoelastic properties of the Hap-decorated versus undecorated hydrogels. Both hydrogel formulations Fmoc-FF/S and Fmoc-FF/S/RGD, w/wo Hap, were subjected to a frequency sweep experiment (frequency range 0.1 to 100 Hz, strain 0.1 %). As shown in Fig. 4A, all hydrogels showed a wide linear viscoelastic region (LVR) with the storage modulus (G’) consistently higher than the loss modulus (G’’) throughout the entire frequency range. This result indicates that both Fmoc-FF/S and Fmoc-FF/S/RGD hydrogels were able to incorporate Hap while still forming a solid-like, hydrogel structure (Fig. 4C). The value of G´ (used as an indicator of hydrogel stiffness) could be modulated according to the formulation used. The two undecorated hydrogels Fmoc-FF/S and Fmoc-FF/S/RGD show similar values in storage modules (6.92 ± 0.33 vs 6.79 ± 0.95 kPa, respectively), indicating that the addition of Fmoc-RGD does not change significantly the mechanical properties between these two hydrogels. Incorporation of Hap to Fmoc-FF/S resulted in apparent 1.2-fold decrease in storage modulus (6.92 ± 0.33 vs 6.07 ± 0.82 kPa, respectively) but the differences were not significant (p-value = 0.8958) (Fig. 4B). On the other hand, addition of Hap to Fmoc-FF/S/RGD resulted in hydrogels with a significant increase in storage modulus compared to both the undecorated Fmoc-FF/S/RGD hydrogels (12.28 ± 0.61 vs 6.79 ± 0.33 kPa, respectively p < 0.005) and the Hap-decorated Fmoc-FF/S hydrogels (12.28 ± 0.61 vs 6.07 ± 0.82 kPa, respectively p < 0.001, Fig. 4B).

Fig. 4.

Fig 4

Analysis of the mechanical properties of the hydrogels studied here. (A) Frequency sweep rheology measurments of Fmoc-FF/S and Fmoc-FF/S/RGD with and without Hap (0.1-100 Hz 0.1 % strain). (B) Comparison of the storage moduli at 1 Hz, 0,1% strain of the Fmoc-FF/S and Fmoc-FF/S/RGD hydrogels with and without Hap. (C) Photographs of the spheroids of Fmoc-FF/S (I), Fmoc-FF/S+Hap (II), Fmoc-FF/S/RGD (III) and Fmoc-FF/S/RGD+Hap (IV) used for the rheology experiments. All measurements were performed at least 3 times at 25 °C. (Data are shown as mean ± SD; ***p-value <0.001; **p-value <0.05).

Our findings also support those of Ghosh and colleagues [42], who demonstrated that Arg-presenting Fmoc-based hydrogels can incorporate Hap nanoparticles to make stiffer scaffolds. In particular, the increase in stiffness occurring in the Fmoc-FF/S/RGD hydrogel when incorporating Hap is greater than for the Fmoc-FF/S hydrogel due to the presence of exposed Arg side chains in the peptide-hydrogel structure. Moreover, in line with our AFM results, it is reasonable to postulate that electrostatic interactions between Arg and Asp side chains from Fmoc-RGD and Ca2+ and PO43− ions from Hap will increase the local supersaturation of Hap nanoparticles, induce a higher number of nanofibre entanglements and fibre-fibre interactions, and will result in hydrogels with superior mechanical properties compared to the hydrogels without either RGD or Hap [46].

3.2. Cytocompatibility and cell morphology analysis of the Hap-decorated hydrogels

The cytocompatibility of the newly developed Hap-decorated scaffolds was examined using Raw 264.7 cells, a murine pre-osteoclast (pre-OC) cell line that is a well-established model to assess OC differentiation and bone-resorbing capability [48]. Three main OC features were used to assess their differentiation: presence/absence of an actin ring, multiple invagination of the cell membrane (hereafter referred to as a ruffled border) and more than three nuclei per cell. As shown in Fig. 5A, an actin ring surrounded all cells in every hydrogel formulation tested, regardless of the presence of Hap. However, when cells were cultured on Fmoc-FF/S/RGD with Hap, they showed a clear difference in morphology: cells appeared well spread with a prominent ruffled border. Moreover, Raw 264.7 cell size significantly increased on the Fmoc-FF/S/RGD hydrogels in the presence of Hap (Fig. 5B); the mean diameter showed that the cells were larger (26.5 ± 4.7 µm) than their counterparts cultured on either the undecorated hydrogels (15.5 ± 2.9 µm) or Fmoc-FF/S with (13.6 ± 1.9 µm) and without Hap (14.1 ± 2.3 µm) (Fig. 5B).

Fig. 5.

Fig 5

Analysis of Raw 264.7 cell culture and differentiation on 15 mM Fmoc-FF/S and Fmoc-FF/S/RGD hydrogels with and without incorporated Hap. (A) F-actin staining of Raw 264.7 cells after seven days culture on the different hydrogels (green: F-actin, Alexa Fluor 488 phalloidin; blue: Nuclei, Hoechst 33342; scale bars 20 µm). (B) Measurements of cell diameter (data shown as mean ± SD, N=43, **p <0.05). (C) Analysis of multinucleation by a violin distribution plot (data shown as number of nuclei per cell, N=100). (D) SEM images of Raw 264.7 cells cultured on Fmoc-FF/S/RGD with or without incorporated Hap. White arrow shows elongated pseudopodia of Raw 264.7-derived OC. (Data are shown as mean ± SD; ***p-value <0.001; **p-value <0.05).

Furthermore, there was evidence of multinucleation on Raw 264/7 cells cultured on Fmoc-FF/S/RGD with incorporated Hap, suggesting OC differentiation (Fig. 5A). A violin plot of the number of nuclei per cell (Fig. 5C) shows that the majority of cells had a single nuclei irrespective of the hydrogel substrate. However, when cultured on Fmoc-FF/S/RGD with incorporated Hap, Raw 264.7 cells showed up to 9 nuclei/cell with a higher number of cells with 4-8 nuclei. This distribution was significantly different from that seen for cells cultured on the other hydrogels (p < 0.0001, non-parametric ANOVA). Cell morphology was also analysed by SEM. Fig. 5D shows differences in morphology of Raw 264.7 cells cultured on Fmoc-FF/S/RGD w/wo Hap. Cells appear rounded and smaller in diameter in the absence of Hap. On the other hand, when cultured in the presence of Hap, cells show a well spread morphology and are larger in diameter, with orientated pseudopodia (Fig. 5D). Interestingly, these pseudopodia spread all around the cell body and are used to create a solid focal adhesion, tightly connected with the hydrogel substrate (Fig. 5D). We believe that two major factors are involved in the observed differentiation of Raw 264.7 cells into OCs when cultured on Fmoc-FF/S/RGD hydrogels with incorporated Hap. The first factor is the presence of the RGD motif in the hydrogel's peptide composition. When binding to bone, OCs form an actin ring-mediated sealing zone that is mediated in part by integrins which are located on the cell membrane and interact with the surrounding ECM. The most important integrin in OC is αvβ3, which strongly interacts with the RGD motif [6,49]. It is known that depletion αvβ3 can cause an impairment in OC differentiation and function [50,51]. Hence, the presence of RGD motifs allows Raw 264.7 cells to adhere better to the Fmoc-FF/S/RGD hydrogels. However, differentiation toward mature OCs only occurred when the Hap was incorporated within the hydrogels. Therefore, our data suggests that the presence of Hap is the second crucial factor for OC-differentiation. Indeed, it has been previously demonstrated that Hap has an effect on pre-OC cells, enhancing the formation of OCs with a pronounced actin ring, protruding pseudopodia and prominent ruffled border [52], [53], [54], similar to the features observed here.

3.3. Hydroxyapatite-decorated hydrogels as substrate for osteoclast culture and differentiation

Having demonstrated the potential of the Fmoc-FF/S/RGD with Hap incorporated system for the culture of pre-OC cells, we conducted additional functional assays to assess cell viability and OC-differentiation. By analysing cell viability we investigated whether Raw 264.7 cells proliferated on our system before differentiating into OCs. LIVE/DEAD staining showed mainly viable cells at 24 h and 48 h (Fig. 6A). Interestingly, from 48 h onward, cells start to form clusters (as shown in the higher magnification inset) and, after 5 days (5d), live cells appear to be larger in size (Fig. 6A, 5d–7d, higher magnification) with little or no clusters present. Furthermore, PicoGreen assay data showed a significant increase of dsDNA over time (p < 0.005), indicating a ∼70% cell proliferation with respect to day 0 baseline control (Fig. 6B).

Fig. 6.

Fig 6

Hap-decorated Fmoc-FF/S/RGD hydrogel functionality. (A) Analyis of viability of Raw 264.7 cells cultured on Fmoc-FF/S/RGD+Hap at different time points using a Live/Dead assay (green: viable cells, calcein AM; red: dead cells, ethidium homodimer-1; scale bar 100 µm). (B) Quantification of dsDNA of Raw 264.7 cells cultured on Fmoc-FF/S/RGD+Hap at different time points, using a PicoGreen fluorescence assay (values normalised to 24 h as baseline control). (C) Visualisation of TRAP expression by immunofluorecence staining (green: F-actin, Alexa Fluor 488 phalloidin; red: TRAP, anti-TRAP mAb conjugated Alexa Fluor 594). (D) Relative TRAP immunofluorescence intensity of cells cultured on Fmoc-FF/S/RGD hydrogels with and without incorporated Hap (fluorescence intensity was measured from at least N=100 cells and corrected against the background). (E) Gene expression of TRAP relative to GAPDH by Raw 264.7 cells (n = 3) after three (D3) and seven (D7) days culture on Hap-decorated Fmoc-FF/S/RGD hydrogel. (Data shown as mean ± SD; ***p <0.001; **p <0.05).

According to these results, we believe that Raw 264.7 cells start their commitment to OC differentiation within 3 days post seeding onto the Fmoc-FF/S/RGD with incorporated Hap hydrogels, and at day 7 they eventually form OCs. For this reason, the increase of dsDNA seen at day 7 is likely to reflect a higher quantity of DNA expressed per cell due to the presence of multinucleated cells (as also shown in Fig. 5A and C), rather than an increase in cell number.

Finally, to confirm the differentiation of Raw 264.7 cells into OCs we assessed the expression of Tartrate-Resistant Acid Phosphatase (TRAP), the most common OC marker [55,56]. TRAP is a phosphatase used by mature OC to acidify the bone microenvironment during their resorption activity. Its expression is localised within the ruffled border area, the lysosomes and the Golgi cisternae [57]. Thus, firstly, we confirmed the expression of this OC marker by using an anti-TRAP monoclonal antibody staining. Raw 264.7 cells cultured on Hap-decorated Fmoc-FF/S/RGD gels showed a positive, bright expression of TRAP localised within the cell membrane (Fig. 6C). Its expression was significantly higher (p<0.005) when compared to Fmoc-FF/S/RGD without Hap (Fig. 6D). Moreover, qRT-PCR was also used to confirm the expression of TRAP when cells were cultured on Fmoc-FF/S/RGD with incorporated Hap. Indeed, since the OC-commitment it is known to begin around days 2–3 [5], we compared the expression of TRAP at day 7 with that at day 3 and we successfully demonstrated that there was a significant increased expression of TRAP at day 7 (Fig. 6E), confirming the OC-differentiation of Raw 264.7 cells cultured on Fmoc-FF/S/RGD with incorporated Hap. Taking into consideration the changes in Raw 264.7 morphology, the increase of multinucleation, and the increase in expression of the OC-typical marker TRAP, we can conclude that our newly developed Hap-decorated hydrogel system is able to support osteoclastogenesis in vitro.

4. Conclusions

In this work, we successfully formulated a Hap-decorated Fmoc-based peptide hydrogel that could be used as a bone-mimicking scaffold for 2D culture and differentiation of OC cells. Our material characterization indicates that the Hap decorates the peptide hydrogels, possibly through a physiochemical interaction between the Fmoc-RGD-functionalised peptide nanofibres and the Hap surface. In particular, it is likely that an attractive electrostatic interaction occurs between the exposed side chains from the RGD motif present on the peptide nanofibres and the Hap nanopowder surface. In fact, both the Arg and Asp side chains of the RGD peptide are likely to participate in the binding of the Hap surface to the Fmoc-FF/S/RGD hydrogel. Molecular dynamics simulations suggest that electrostatic interactions play a dominant role in the binding of peptides and proteins to Hap surfaces and that charged groups such as carboxylate, amine or guanidine may interact with the calcium, phosphate and hydroxide ions on the Hap crystal lattice [58], [59], [60]. This could explain the increased mechanical properties (raise of G') observed for Fmoc-FF/S/RGD incorporating Hap compared to the other hydrogels, as shown in Fig. 4A. Our findings are consistent with published data showing that hydrogels based on amino acids with ionic side chains can incorporate Hap nanoparticles to make stiffer scaffolds, probably by forming strong interactions with Ca2+ and PO43− ions coming from dissolved Hap [41,61,62,42]. The Hap-decorated Fmoc-FF/S/RGD hydrogels show potential as platforms to culture and differentiate Raw 264.7 cells toward mature OCs. In particular, the presence of both RGD motifs and Hap within these hydrogels supported the viability of cultured Raw 264.7 cells over time and triggered their differentiation into mature OCs. This differentiation was confirmed by changes in cellular morphology (significant increase in multinucleation, ruffled border, and cell diameter) and by increased expression of TRAP, a typical OC marker [55]. Unlike other different hydrogel systems for culturing OC (such as gellan gum, alginate or hyaluronic acid hydrogels [63], [64], [65]), our system resembles the typical OC-bone interface. In fact, despite its limitations (e.g. 2D platform, lack of collagen component, mechanical properties not as stiff as native tissue), due to the presence of the RGD motif, OCs interact with a biomineralised peptide surface in an active way through typical RGD-integrin binding (integrin αvβ3) [51]. Importantly, though, our functionalised hydrogel supports osteoclastogenesis in vitro and does not require the presence of inducing factors such as RANKL [66] to generate mature OCs. All these results suggest that the Hap-decorated hydrogels developed here could provide a material platform to design more complex and translatable biomaterials for OC culture and differentiation. Moreover, such hydrogels may help to investigate and develop novel in vitro models for bone regeneration/resorption studies. For example, this system could be loaded with drugs that inhibit OC differentiation [67] to develop more efficient pharmacological treatments to tackle excessive bone degradation, as it occurs in osteoporosis, osteoarthritis, and cancers.

Declaration of Competing Interest

The authors declare the following personal relationships which may be considered as potential competing interests: At the time of submission, CA was employed by Biogelx Ltd.

Acknowledgements

This work was supported by an MRC CASE PhD studentship to MV (reference MR/R105767/1), and a BBSRC Flexible Talent Mobility Account to JB and BM (BB/S507969/1). CL acknowledges the financial support from the EPSRC Doctoral Prize Fellowship (EP/T517823/1). The authors thank Mr David Smith and the staff in the EM Core Facility in the Faculty of Biology, Medicine and Health for their assistance, and the Wellcome Trust for equipment grant support to the EM Core Facility. The Bioimaging Facility microscopes used in this study were purchased with grants from BBSRC, Wellcome and the University of Manchester Strategic Fund. Special thanks goes to Dr Steven Marsden for his help with the microscopy.

Footnotes

Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.actbio.2021.11.011.

Contributor Information

Stephen M. Richardson, Email: s.richardson@manchester.ac.uk.

Judith A. Hoyland, Email: judith.hoyland@manchester.ac.uk.

Jordi Bella, Email: jordi.bella@manchester.ac.uk.

Appendix. Supplementary materials

mmc1.docx (1.5MB, docx)

References

  • 1.Currey J.D. How well are bones designed to resist fracture? J. Bone Miner. Res. 2003;18:591–598. doi: 10.1359/jbmr.2003.18.4.591. [DOI] [PubMed] [Google Scholar]
  • 2.Reznikov N., Shahar R., Weiner S. Acta Biomater. Elsevier Ltd; 2014. Bone hierarchical structure in three dimensions; pp. 3815–3826. [DOI] [PubMed] [Google Scholar]
  • 3.Sims N.A., Martin T.J. Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit. Bonekey Rep. 2014;3 doi: 10.1038/bonekey.2013.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Weiner S., Traub W. Bone structure: from angstroms to microns. FASEB J. 1992;6:879–885. doi: 10.1096/fasebj.6.3.1740237. [DOI] [PubMed] [Google Scholar]
  • 5.Nedeva I.R., Vitale M., Elson A., Hoyland J.A., Bella J. Role of OSCAR signaling in osteoclastogenesis and bone disease. Front. Cell Dev. Biol. 2021;9 doi: 10.3389/fcell.2021.641162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Phan T.C.A., Xu J., Zheng M.H. Interaction between osteoblast and osteoclast: impact in bone disease. Histol. Histopathol. 2004;19:1325–1344. doi: 10.14670/HH-19.1325. [DOI] [PubMed] [Google Scholar]
  • 7.Novack D.V., Mbalaviele G. Osteoclasts-key players in skeletal health and disease. Microbiol. Spectr. 2016;4 doi: 10.1128/microbiolspec.MCHD-0011-2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Raimondi L., De Luca A., Amodio N., Manno M., Raccosta S., Taverna S., Bellavia D., Naselli F., Fontana S., Schillaci O., Giardino R., Fini M., Tassone P., Santoro A., De Leo G., Giavaresi G., Alessandro R. Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation. Oncotarget. 2015;6:13772–13789. doi: 10.18632/oncotarget.3830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Roi A., Ardelean L.C., Roi C.I., Boia E.R., Boia S., Rusu L.C. Oral bone tissue engineering: Advanced biomaterials for cell adhesion, proliferation and differentiation. Mater. (Basel) 2019;12 doi: 10.3390/ma12142296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Zhang Y., Wu D., Zhao X., Pakvasa M., Tucker A.B., Luo H., Qin K.H., Hu D.A., Wang E.J., Li A.J., Zhang M., Mao Y., Sabharwal M., He F., Niu C., Wang H., Huang L., Shi D., Liu Q., Ni N., Fu K., Chen C., Wagstaff W., Reid R.R., Athiviraham A., Ho S., Lee M.J., Hynes K., Strelzow J., He T.C., El Dafrawy M. Stem cell-friendly scaffold biomaterials: applications for bone tissue engineering and regenerative medicine. Front. Bioeng. Biotechnol. 2020;8 doi: 10.3389/fbioe.2020.598607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ahmed E.M. Hydrogel: preparation, characterization, and applications: a review. J. Adv. Res. 2015;6:105–121. doi: 10.1016/j.jare.2013.07.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Bai X., Gao M., Syed S., Zhuang J., Xu X., Zhang X.Q. Bioactive hydrogels for bone regeneration. Bioact. Mater. 2018;3:401–417. doi: 10.1016/j.bioactmat.2018.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Puppi D., Chiellini F., Piras A.M., Chiellini E. Polymeric materials for bone and cartilage repair. Prog. Polym. Sci. 2010;35:403–440. doi: 10.1016/j.progpolymsci.2010.01.006. [DOI] [Google Scholar]
  • 14.Simeonov M.S., Apostolov A.A., Vassileva E.D. In situ calcium phosphate deposition in hydrogels of poly(acrylic acid)-polyacrylamide interpenetrating polymer networks. RSC Adv. 2016;6:16274–16284. doi: 10.1039/c5ra26066c. [DOI] [Google Scholar]
  • 15.Detsch R., Boccaccini A.R. The role of osteoclasts in bone tissue engineering. J. Tissue Eng. Regen. Med. 2015;9:1133–1149. doi: 10.1002/term.1851. [DOI] [PubMed] [Google Scholar]
  • 16.Ligorio C., O'Brien M., Hodson N.W., Mironov A., Iliut M., Miller A.F., Vijayaraghavan A., Hoyland J.A., Saiani A. TGF-β3-loaded graphene oxide - self-assembling peptide hybrid hydrogels as functional 3D scaffolds for the regeneration of the nucleus pulposus. Acta Biomater. 2021;127:116–130. doi: 10.1016/j.actbio.2021.03.077. [DOI] [PubMed] [Google Scholar]
  • 17.Chiesa I., Ligorio C., Bonatti A.F., De Acutis A., Smith A.M., Saiani A., Vozzi G., De Maria C. Modeling the three-dimensional bioprinting process of β-sheet self-assembling peptide hydrogel scaffolds. Front. Med. Technol. 2020;2:4. doi: 10.3389/fmedt.2020.571626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Imere A., Ligorio C., O'Brien M., Wong J.K.F., Domingos M., Cartmell S.H. Engineering a cell-hydrogel-fibre composite to mimic the structure and function of the tendon synovial sheath. Acta Biomater. 2021;119:140–154. doi: 10.1016/j.actbio.2020.11.017. [DOI] [PubMed] [Google Scholar]
  • 19.Hellmund K.S., Koksch B. Self-assembling peptides as extracellular matrix mimics to influence stem cell's fate. Front. Chem. 2019;7 doi: 10.3389/fchem.2019.00172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ulijn R.V., Smith A.M. Designing peptide based nanomaterials. Chem. Soc. Rev. 2008;37:664–675. doi: 10.1039/b609047h. [DOI] [PubMed] [Google Scholar]
  • 21.Reches M., Gazit E. Casting metal nanowires within discrete self-assembled peptide nanotubes. Science (80-. ) 2003;300:625–627. doi: 10.1126/science.1082387. [DOI] [PubMed] [Google Scholar]
  • 22.Jayawarna V., Ali M., Jowitt T.A., Miller A.F., Saiani A., Gough J.E., Ulijn R.V. Nanostructured hydrogels for three-dimensional cell culture through self-assembly of fluorenylmethoxycarbonyl-dipeptides. Adv. Mater. 2006;18:611–614. doi: 10.1002/adma.200501522. [DOI] [Google Scholar]
  • 23.Diaferia C., Morelli G., Accardo A. Fmoc-diphenylalanine as a suitable building block for the preparation of hybrid materials and their potential applications. J. Mater. Chem. B. 2019;7:5142–5155. doi: 10.1039/c9tb01043b. [DOI] [PubMed] [Google Scholar]
  • 24.Jayawarna V., Richardson S.M., Hirst A.R., Hodson N.W., Saiani A., Gough J.E., Ulijn R.V. Introducing chemical functionality in Fmoc-peptide gels for cell culture. Acta Biomater. 2009;5:934–943. doi: 10.1016/j.actbio.2009.01.006. [DOI] [PubMed] [Google Scholar]
  • 25.Zhou M., Smith A.M., Das A.K., Hodson N.W., Collins R.F., Ulijn R.V., Gough J.E. Self-assembled peptide-based hydrogels as scaffolds for anchorage-dependent cells. Biomaterials. 2009;30:2523–2530. doi: 10.1016/j.biomaterials.2009.01.010. [DOI] [PubMed] [Google Scholar]
  • 26.Harper M.M., Connolly M.L., Goldie L., Irvine E.J., Shaw J.E., Jayawarna V., Richardson S.M., Dalby J., Lightbody D., Ulijn R.V. Biogelx : cell culture on gels based on aromatic peptide amphiphiles. Methods Mol. Biol. 2018;1777:283–303. doi: 10.1007/978-1-4939-7811-3_18. [DOI] [PubMed] [Google Scholar]
  • 27.Sant S., Hancock M.J., Donnelly J.P., Iyer D., Khademhosseini A. Biomimetic gradient hydrogels for tissue engineering. Can. J. Chem. Eng. 2010;88:899–911. doi: 10.1002/cjce.20411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ligorio C., Zhou M., Wychowaniec J.K., Zhu X., Bartlam C., Miller A.F., Vijayaraghavan A., Hoyland J.A., Saiani A. Graphene oxide containing self-assembling peptide hybrid hydrogels as a potential 3D injectable cell delivery platform for intervertebral disc repair applications. Acta Biomater. 2019:0–11. doi: 10.1016/j.actbio.2019.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Xavier J.R., Thakur T., Desai P., Jaiswal M.K., Sears N., Cosgriff-Hernandez E., Kaunas R., Gaharwar A.K. Bioactive nanoengineered hydrogels for bone tissue engineering: a growth-factor-free approach. ACS Nano. 2015;9:3109–3118. doi: 10.1021/nn507488s. [DOI] [PubMed] [Google Scholar]
  • 30.Hu Y., Chen J., Fan T., Zhang Y., Zhao Y., Shi X., Zhang Q. Biomimetic mineralized hierarchical hybrid scaffolds based on in situ synthesis of nano-hydroxyapatite/chitosan/chondroitin sulfate/hyaluronic acid for bone tissue engineering. Colloids Surf. B Biointerfaces. 2017;157:93–100. doi: 10.1016/j.colsurfb.2017.05.059. [DOI] [PubMed] [Google Scholar]
  • 31.Suvarnapathaki S., Wu X., Lantigua D., Nguyen M.A., Camci-Unal G. Hydroxyapatite-incorporated composite gels improve mechanical properties and bioactivity of bone scaffolds. Macromol. Biosci. 2020;20 doi: 10.1002/mabi.202000176. 2000176. [DOI] [PubMed] [Google Scholar]
  • 32.Ma X., He Z., Han F., Zhong Z., Chen L., Li B. Preparation of collagen/hydroxyapatite/alendronate hybrid hydrogels as potential scaffolds for bone regeneration. Colloids Surf. B Biointerfaces. 2016;143:81–87. doi: 10.1016/j.colsurfb.2016.03.025. [DOI] [PubMed] [Google Scholar]
  • 33.Tozzi G., De Mori A., Oliveira A., Roldo M. Composite hydrogels for bone regeneration. Mater. (Basel) 2016;9:267. doi: 10.3390/ma9040267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Gkioni K., Leeuwenburgh S.C.G., Douglas T.E.L., Mikos A.G., Jansen J.A. Mineralization of hydrogels for bone regeneration. Tissue Eng. Part B Rev. 2010;16:577–585. doi: 10.1089/ten.teb.2010.0462. [DOI] [PubMed] [Google Scholar]
  • 35.Boskey A.L. Bone composition: relationship to bone fragility and antiosteoporotic drug effects. Bonekey Rep. 2013;2 doi: 10.1038/bonekey.2013.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kattimani V.S., Kondaka S., Lingamaneni K.P. Hydroxyapatite-past, present, and future in bone regeneration. Bone Tissue Regen. Insights. 2016;7 doi: 10.4137/btri.s36138. BTRI.S36138. [DOI] [Google Scholar]
  • 37.J.C. Taylor, S.E. Cuff, J.P.L. Leger, A. Morra, G.I. Anderson, In vitro osteoclast resorption of bone substitute biomaterials used for implant site augmentation: a pilot study, Int. J. Oral Maxillofac. Implants. 17 (n.d.) 321–30. [PubMed]
  • 38.Chen F., Wang M., Wang J., Chen X., Li X., Xiao Y., Zhang X. Effects of hydroxyapatite surface nano/micro-structure on osteoclast formation and activity. J. Mater. Chem. B. 2019;7:7574–7587. doi: 10.1039/c9tb01204d. [DOI] [PubMed] [Google Scholar]
  • 39.Huang L.K., Wang M.J.J. Image thresholding by minimizing the measures of fuzziness. Pattern Recognit. 1995;28:41–51. doi: 10.1016/0031-3203(94)E0043-K. [DOI] [Google Scholar]
  • 40.Soille P., Vincent L.M. Proc. SPIE 1360, Visual Communications and Image Processing '90: Fifth in a Series. SPIE; 1990. Determining watersheds in digital pictures via flooding simulations; pp. 240–250. [DOI] [Google Scholar]
  • 41.Tavafoghi Jahromi M., Yao G., Cerruti M. The importance of amino acid interactions in the crystallization of hydroxyapatite. J. R. Soc. Interface. 2013;10 doi: 10.1098/rsif.2012.0906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Ghosh M., Halperin-Sternfeld M., Grigoriants I., Lee J., Nam K.T., Adler-Abramovich L. Arginine-presenting peptide hydrogels decorated with hydroxyapatite as biomimetic scaffolds for bone regeneration. Biomacromolecules. 2017;18:3541–3550. doi: 10.1021/acs.biomac.7b00876. [DOI] [PubMed] [Google Scholar]
  • 43.Green H., Ochbaum G., Gitelman-Povimonsky A., Bitton R., Rapaport H. RGD-presenting peptides in amphiphilic and anionic β-sheet hydrogels for improved interactions with cells. RSC Adv. 2018;8:10072–10080. doi: 10.1039/c7ra12503h. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Kwon T., Sung B.J. Effects of nanoparticles on the stability of polymer fibers. Phys. Rev. E. 2018;98:42503. doi: 10.1103/PhysRevE.98.042503. [DOI] [Google Scholar]
  • 45.Tavafoghi Jahromi M., Yao G., Cerruti M. The importance of amino acid interactions in the crystallization of hydroxyapatite. J. R. Soc. Interface. 2013;10 doi: 10.1098/rsif.2012.0906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Tavafoghi M., Brodusch N., Gauvin R., Cerruti M. Hydroxyapatite formation on graphene oxide modified with amino acids: Arginine versus glutamic acid. J. R. Soc. Interface. 2016;13 doi: 10.1098/rsif.2015.0986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Rivas M., Del Valle L.J., Alemán C., Puiggalí J. Peptide self-assembly into hydrogels for biomedical applications related to hydroxyapatite. Gels. 2019;5:1–29. doi: 10.3390/gels5010014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Marino S., Logan J.G., Mellis D., Capulli M. Generation and culture of osteoclasts. Bonekey Rep. 2014;3:1–9. doi: 10.1038/bonekey.2014.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Teitelbaum S.L., Ross F.P. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 2003;4:638–649. doi: 10.1038/nrg1122. [DOI] [PubMed] [Google Scholar]
  • 50.Zou W., Teitelbaum S.L. Absence of Dap12 and the αvβ3 integrin causes severe osteopetrosis. J. Cell Biol. 2015;208:125–136. doi: 10.1083/jcb.201410123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Nakamura I., Duong L.T., Rodan S.B., Rodan G.A. Involvement of αvβ3 integrins in osteoclast function. J. Bone Miner. Metab. 2007;25:337–344. doi: 10.1007/s00774-007-0773-9. [DOI] [PubMed] [Google Scholar]
  • 52.Detsch R., Mayr H., Ziegler G. Formation of osteoclast-like cells on HA and TCP ceramics. Acta Biomater. 2008;4:139–148. doi: 10.1016/j.actbio.2007.03.014. [DOI] [PubMed] [Google Scholar]
  • 53.Botelho C.M., Brooks R.A., Spence G., McFarlane I., Lopes M.A., Best S.M., Santos J.D., Rushton N., Bonfield W. Differentiation of mononuclear precursors into osteoclasts on the surface of Si-substituted hydroxyapatite. J. Biomed. Mater. Res. Part A. 2006;78:709–720. doi: 10.1002/jbm.a.30726. [DOI] [PubMed] [Google Scholar]
  • 54.Ciapetti G., Di Pompo G., Avnet S., Martini D., Diez-Escudero A., Montufar E.B., Ginebra M.P., Baldini N. Osteoclast differentiation from human blood precursors on biomimetic calcium-phosphate substrates. Acta Biomater. 2017;50:102–113. doi: 10.1016/j.actbio.2016.12.013. [DOI] [PubMed] [Google Scholar]
  • 55.Hayman A. Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy. Autoimmunity. 2008;41:218–223. doi: 10.1080/08916930701694667. [DOI] [PubMed] [Google Scholar]
  • 56.Ballanti P., Minisola S., Pacitti M.T., Scarnecchia L., Rosso R., Mazzuoli G.F., Bonucci E. Tartrate-resistant acid phosphate activity as osteoclastic marker: Sensitivity of cytochemical assessment and serum assay in comparison with standardized osteoclast histomorphometry. Osteoporos. Int. 1997;7:39–43. doi: 10.1007/BF01623458. [DOI] [PubMed] [Google Scholar]
  • 57.Ljusberg J., Wang Y., Lång P., Norgård M., Dodds R., Hultenby K., Ek-Rylander B., Andersson G. Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts. J. Biol. Chem. 2005;280:28370–28381. doi: 10.1074/jbc.M502469200. [DOI] [PubMed] [Google Scholar]
  • 58.Shen J.W., Wu T., Wang Q., Pan H.H. Molecular simulation of protein adsorption and desorption on hydroxyapatite surfaces. Biomaterials. 2008;29:513–532. doi: 10.1016/j.biomaterials.2007.10.016. [DOI] [PubMed] [Google Scholar]
  • 59.Zhao W., Xu Z., Cui Q., Sahai N. Predicting the structure-activity relationship of hydroxyapatite-binding peptides by enhanced-sampling molecular simulation. Langmuir. 2016;32:7009–7022. doi: 10.1021/acs.langmuir.6b01582. [DOI] [PubMed] [Google Scholar]
  • 60.Ling C., Zhao W., Wang Z., Chen J., Ustriyana P., Gao M., Sahai N. Structure-activity relationships of hydroxyapatite-binding peptides. Langmuir. 2020;36:2729–2739. doi: 10.1021/acs.langmuir.9b03779. [DOI] [PubMed] [Google Scholar]
  • 61.Tavafoghi M., Cerruti M. The role of amino acids in hydroxyapatite mineralization. J. R. Soc. Interface. 2016:13. doi: 10.1098/rsif.2016.0462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Palazzo B., Walsh D., Iafisco M., Foresti E., Bertinetti L., Martra G., Bianchi C.L., Cappelletti G., Roveri N. Amino acid synergetic effect on structure, morphology and surface properties of biomimetic apatite nanocrystals. Acta Biomater. 2009;5:1241–1252. doi: 10.1016/j.actbio.2008.10.024. [DOI] [PubMed] [Google Scholar]
  • 63.Maia F.R., Musson D.S., Naot D., Da Silva L.P., Bastos A.R., Costa J.B., Oliveira J.M., Correlo V.M., Reis R.L., Cornish J. Differentiation of osteoclast precursors on gellan gum-based spongy-like hydrogels for bone tissue engineering. Biomed. Mater. 2018:13. doi: 10.1088/1748-605X/aaaf29. [DOI] [PubMed] [Google Scholar]
  • 64.Zehnder T., Boccaccini A.R., Detsch R. Biofabrication of a co-culture system in an osteoid-like hydrogel matrix. Biofabrication. 2017;9 doi: 10.1088/1758-5090/aa64ec. [DOI] [PubMed] [Google Scholar]
  • 65.Hulley P.A., Papadimitriou-Olivgeri I., Knowles H.J. Osteoblast–osteoclast coculture amplifies inhibitory effects of FG-4592 on human osteoclastogenesis and reduces bone resorption. JBMR Plus. 2020;4:e10370. doi: 10.1002/jbm4.10370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Collin-Osdoby P., Osdoby P. Bone Res. Protoc., Humana Press; Totowa, NJ: 2012. RANKL-Mediated Osteoclast Formation from Murine RAW 264.7 cells; pp. 187–202. [DOI] [PubMed] [Google Scholar]
  • 67.Aderibigbe B., Aderibigbe I., Popoola P. Design and biological evaluation of delivery systems containing bisphosphonates. Pharmaceutics. 2017;9 doi: 10.3390/pharmaceutics9010002. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

mmc1.docx (1.5MB, docx)

RESOURCES